The project is worth over 1.8 billion rubles and is designed to provide access to important medicines.

The company Argumentum Pharma has started construction in this area and has already achieved significant results by constructing the columns and frame of the building. The first phase of the research and production complex, which will cover an area of ​​over 6.5 thousand square meters, is planned to be completed by the end of the second quarter of 2025.

The press service explained that the plant will produce a variety of medicines, including drugs to stabilize blood pressure, treat arrhythmia, as well as analgesics and drugs for the treatment of rheumatic and oncological diseases.

In the first phase, the enterprise will be able to produce more than 55 million units of medicine per year and create more than 100 jobs, and after the commissioning of the second phase, it will have the opportunity to expand additional staff. This project will be implemented with the support of the Moscow Region Development Corporation.

Source: Ferra

Previous articleRussian President orders the establishment of three new “megasscience” scientific facilities in Russia22:10 | October 21, 2023
Next articleThe infamous ICC was subjected to a powerful cyber attack “for espionage purposes”. Science and technology22:27 | October 21, 2023
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.

LEAVE A REPLY

Please enter your comment!
Please enter your name here